Health
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A
Continue Reading
-
Noosa News17 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business20 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General15 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News19 hours agoAnother whale calf caught in Noosa nets